Insulin-like growth factor (IGF)-I binding to a cell membrane associated IGF binding protein-3 acid-labile subunit complex in human anterior pituitary gland

Journal of Neurochemistry

Volumn 82, Issue 2, 2002, Pages 430-438

  Wilczak, Nadine ^a   Kühl, Nicole ^a   Chesik, Daniel ^a   Geerts, Albert ^b   Luiten, Paul ^c   De Keyser, Jacques ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Acid labile subunit; Human brain; IGFBP 3; Insulin like growth factor binding proteins; Insulin like growth factor I; Pituitary gland

Indexed keywords

ACID; IODINE 125; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN SUBUNIT; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADENOHYPOPHYSIS; ADULT; AGED; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING COMPETITION; BINDING SITE; BRAIN; BRAIN REGION; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; MOLECULAR WEIGHT; NEUROHYPOPHYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

AGED; BINDING, COMPETITIVE; BLOTTING, WESTERN; CARRIER PROTEINS; CELL MEMBRANE; FEMALE; FRONTAL LOBE; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MACROMOLECULAR SUBSTANCES; MALE; MIDDLE AGED; PITUITARY GLAND, ANTERIOR; PRECIPITIN TESTS; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036069936     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00979.x     Document Type: Article

References (38)

1. Anatomy of the pituitary insulin-like growth factor system
2. Natural and synthetic forms of insulin-like growth factor-I (IGF-I) and the potent derivative, destripeptide IGF-I: Biological activities and receptor binding
3. Insulin and insulin-like growth factors in the CNS
4. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex
5. Insulin-like growth factor binding proteins in the human circulation: A review
6. r 140,000 growth hormone dependent insulin-like growth factor binding protein complex: Determination by reconstitution and affinity-labeling
7. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum
8. Localization of binding sites for insulin-like growth factor I (IGF-I) in the rat brain by quantitative autoradiography
9. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction
10. Role of insulin-like growth factor binding proteins in controlling IGF actions
11. The role of the insulin-like growth factors in the central nervous system
12. Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex
13. Insulin-like growth factor-I receptors in human brain and pituitary gland: An autoradiographic study
14. The insulin-like growth factor-binding protein (IGFBP) superfamily
15. Insulin-like growth factors and their binding proteins: Biological actions
16. 125I] insulin receptor binding sites in developing and adult rat brain
17. Structure and function of the mannose-6-phosphate/insulin-like growth factor II receptors
18. Molecular and cellular aspects of the insulin-like growth factor 1 receptor
19. Receptors for insulin-like growth factors I and -II, autoradiographic localization in rat brain and comparison to receptors for insulin
20. Protein measurement with the folin phenol reagent
21. Insulin-like growth factor binding protein-3: Biochemistry and physiology
22. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity for its ligand: An alternative mechanism in the regulation of IGF action
23. Insulin-like growth factor II receptors as a multifunctional binding protein
24. Stimulatory effect of insulin-like growth factor I on proliferation of mouse pituitary cells in serum-free culture
25. Regulatory actions of insulin-like growth factor binding proteins
26. The insulin-like growth factor binding protein superfamily: New perspectives
27. Identification of retinal insulin receptors using site-specific antibodies to a carboxyl-terminal peptide of the human insulin receptor alphasubunit. Up-regulation of neuronal receptors in diabetes
28. Synthesis of the acid-labile subunit of the growth-hormone-dependent insulin-like-growth-factor-binding protein complex by rat hepatocytes in culture
29. Mechanism of Sertoli cell insulin-like growth factor (IGF)-binding protein-3 regulation by IGF-I and adenosine 3′,5′-monophosphate
30. Insulin like growth factor binding proteins
31. The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-I for binding
32. Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats
33. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative temary complex with IGFs and the acid-labile subunit
34. Insulin-like growth factor binding protein 5 complexes with the acid-labile subunit. Role of the carboxy-terminal domain
35. Porcine ovarian cells express messenger ribonucleic acids for the acid-labile subunit and insulin-like growth factor binding protein-3 during follicular and luteal phases of the estrous cycle
36. Insulin-like growth factor II receptors in human brain and their absence in astrogliotic plaques in multiple sclerosis
37. Rat pituitary GC cell insulin-like growth factor-I receptor regulation
38. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs